Biocept, Inc. filed a voluntary petition liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware on October 13, 2023. The debtor listed its assets of $2.49 million and liabilities of $2.92 million. The debtor is represented by Matthew P. Ward of Womble Bond Dickinson (US) LLP as its legal counsel.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
04-26 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
04-02 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 2 | |
-1.29% | 12.64B | |
-0.47% | 8.37B | |
+5.68% | 5.37B | |
+22.66% | 5.26B | |
-2.03% | 4.58B | |
-53.48% | 3.16B | |
+19.30% | 2.89B | |
-8.42% | 2.22B | |
-3.55% | 1.91B |
- Stock Market
- Equities
- BIOCQ Stock
- News Biocept, Inc.
- Biocept, Inc. Filed for Bankruptcy